Mutations in glucocerebrosidase lead to Parkinson’s and Gaucher disease. This study reports the characterization of nanobodies that improve glucocerebrosidase functionality using an allosteric mechanism. This paves the way for alternative therapeutic routes.
- Thomas Dal Maso
- Chiara Sinisgalli
- Nicoletta Plotegher